Literature DB >> 18162467

Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence.

Maki Fukami1, Yuka Wada, Michiyo Okada, Fumiko Kato, Noriyuki Katsumata, Takashi Baba, Ken-ichirou Morohashi, Jocelyn Laporte, Motoo Kitagawa, Tsutomu Ogata.   

Abstract

Although chromosome X open reading frame 6 (CXorf6) has been shown to be a causative gene for hypospadias, its molecular function remains unknown. To clarify this, we first examined CXorf6 protein structure, identifying homology to mastermind-like 2 (MAML2) protein, which functions as a co-activator in canonical Notch signaling. Transactivation analysis for wild-type CXorf6 protein by luciferase assays showed that CXorf6 significantly transactivated the promoter of a noncanonical Notch target gene hairy/enhancer of split 3 (Hes3) without demonstrable DNA-binding capacity. Transactivation analysis was also performed for the previously described three apparently pathologic nonsense mutations, indicating that E124X and Q197X proteins had no transactivation function, whereas R653X protein retained a nearly normal transactivation function. Subcellular localization analysis revealed that wild-type and R653X proteins co-localized with MAML2 protein in nuclear bodies, whereas E124X and Q197X proteins were incapable of localizing to nuclear bodies. Thus, further studies were performed for R653X, revealing the occurrence of nonsense mediated mRNA decay in vivo. Next, transient knockdown of CXorf6 was performed using small interfering RNA, showing reduced testosterone production in mouse Leydig tumor cells. Furthermore, steroidogenic factor 1 (SF1) protein bound to a specific sequence in the upstream of the CXorf6 coding region and exerted a transactivation activity. These results suggest that CXorf6 transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence, thereby providing the first clue to clarify the biological role of CXorf6. We designate CXorf6 as MAMLD1 (mastermind-like domain-containing 1) based on its characteristic structure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162467     DOI: 10.1074/jbc.M703289200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Disorders of sex development: new genes, new concepts.

Authors:  Makoto Ono; Vincent R Harley
Journal:  Nat Rev Endocrinol       Date:  2012-12-18       Impact factor: 43.330

2.  Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development.

Authors:  Elizabeth J Bhoj; Purita Ramos; Linda A Baker; Vidu Garg; Nicholas Cost; Agneta Nordenskjöld; Frederick F Elder; Steven B Bleyl; Neil E Bowles; Cammon B Arrington; Brigitte Delhomme; Amandine Vanhoutteghem; Philippe Djian; Andrew R Zinn
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

3.  A New MAMLD1 Variant in an Infant With Microphallus and Hypospadias With Hormonal Pattern Suggesting Partial Hypogonadotropic Hypogonadism-Case Report.

Authors:  Diego Yeste; Cristina Aguilar-Riera; Gennaro Canestrino; Paula Fernández-Alvarez; María Clemente; Núria Camats-Tarruella
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 4.  The Genetic and Environmental Factors Underlying Hypospadias.

Authors:  Aurore Bouty; Katie L Ayers; Andrew Pask; Yves Heloury; Andrew H Sinclair
Journal:  Sex Dev       Date:  2015-11-28       Impact factor: 1.824

5.  Polymorphism of 3' UTR of MAMLD1 gene is also associated with increased risk of isolated hypospadias in Indian children: a preliminary report.

Authors:  Simmi K Ratan; Anju Sharma; Seema Kapoor; Sunil K Polipalli; Divya Dubey; Tarun K Mishra; Shandip K Sinha; Satish K Agarwal
Journal:  Pediatr Surg Int       Date:  2016-01-27       Impact factor: 1.827

6.  Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development.

Authors:  Mami Miyado; Michiko Nakamura; Kenji Miyado; Ken-Ichirou Morohashi; Shinichiro Sano; Eiko Nagata; Maki Fukami; Tsutomu Ogata
Journal:  Endocrinology       Date:  2012-10-18       Impact factor: 4.736

Review 7.  Role of Liquid-Liquid Separation in Endocrine and Living Cells.

Authors:  Kazuhisa Akiba; Yuko Katoh-Fukui; Kei Yoshida; Satoshi Narumi; Mami Miyado; Yukihiro Hasegawa; Maki Fukami
Journal:  J Endocr Soc       Date:  2021-07-19

8.  Mamld1 knockdown reduces testosterone production and Cyp17a1 expression in mouse Leydig tumor cells.

Authors:  Michiko Nakamura; Maki Fukami; Fumihiro Sugawa; Mami Miyado; Katsuya Nonomura; Tsutomu Ogata
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Screening of MAMLD1 mutations in 70 children with 46,XY DSD: identification and functional analysis of two new mutations.

Authors:  Nicolas Kalfa; Maki Fukami; Pascal Philibert; Francoise Audran; Catherine Pienkowski; Jacques Weill; Graziella Pinto; Sylvie Manouvrier; Michel Polak; Totsumo Ogata; Charles Sultan
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

10.  miR-1322 Binding Sites in Paralogous and Orthologous Genes.

Authors:  Raigul Niyazova; Olga Berillo; Shara Atambayeva; Anna Pyrkova; Aigul Alybayeva; Anatoly Ivashchenko
Journal:  Biomed Res Int       Date:  2015-05-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.